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Susceptibility of Human Pancreatic A Cells for
Cytomegalovirus Infection and the Effects on
Cellular Immunogenicity
Maaike J. Smelt, PhD,* Marijke M. Faas, PhD,* Bart J. de Haan, BSc,* Christina Draijer, MSc,*
Greg C.G. Hugenholtz, MSc,* Aalzen de Haan, PhD,Þ Marten A. Engelse, PhD,þ
Eelco J.P. de Koning, MD, PhD,þ and Paul de Vos, PhD*
Objectives: Human cytomegalovirus (HCMV) infection has been
suggested to be a causal factor in the development of type 1 diabetes,
posttransplantation diabetes, and the failure of islet allografts. This ef-
fect of CMV has been interpreted as an indirect effect on the immune
system rather than direct infectionYinduced cell death. In the present
study, we investigated (i) the susceptibility of A cells to HCMV infec-
tion, (ii) regulation of immune cellYactivating ligands, (iii) release of
proinﬂammatory cytokines, and (iv) the effects on peripheral blood mo-
nonuclear cell (PBMC) activation.
Methods: CM insulinoma cells andprimaryA cells were HCMV-infected
in vitro using a laboratory and a clinical HCMV strain. The susceptibility to
infection was measured by the expression of viral genes and proteins.
Furthermore, expression levels of Major Histocompatibility Complex I,
Intracellular Adhesion Molecule-1, and Lymphocyte Function Associated
Antigen-3 and the release of proinﬂammatory cytokines were determined.
In addition, PBMC activation to HCMV-infected A cells was determined.
Results: A Cells were susceptible to HCMV infection. Moreover, the
infection increased the cellular immunogenicity, as demonstrated by
an increased MHC I and ICAM-1 expression and an increased proin-
ﬂammatory cytokine release. Human cytomegalovirusYinfected CM
cells potently activated PBMCs. The infection-induced effects were de-
pendent on both viral ‘‘sensing’’ and viral replication.
Conclusions: In vivo A-cell HCMV infection and infection-enhanced
cellular immunogenicity may have important consequences for native
or transplanted A-cell survival.
Key Words: cytomegalovirus, A cells, immunogenicity,
immune cell activation
(Pancreas 2012;41: 39Y49)
H uman cytomegalovirus (HCMV) may contribute to A-cell dysfunction in new-onset type 1 diabetes mellitus,1Y5
the development of diabetes mellitus after solid-organ
transplantation,6Y8 and islet allograft failure.9Y11 Because direct
CMV infection of the pancreatic islets was never indisputably
proven, the diabetogenic potential of CMV still remains a
subject of debate and the exact mechanism of CMV-induced A-
cell dysfunction remains to be clariﬁed. In most studies
addressing the effect of CMV infection on the development of
diabetes, the accelerating effect of CMV has been interpreted
as a CMV-induced reinforcement of existing autoimmune
responses,1,5 rather than direct cytolytic infection of A cells.1Y4
However, knowledge on the cellular and molecular basis of
these observations is largely lacking.
Cytomegalovirus belongs to the family of A-herpes viruses
and is the largest and most complex member of this family.12
Owing to several immunoevasive strategies, the virus establishes
a symptomless but persistent infection in healthy individuals.
However, in immunocompromised individuals, owing to the lack
of immunologic control, the virus is able to reactivate and to
cause severe CMV disease. Viral activity can be observed in all
organs, including the pancreas,13 demonstrating that the virus has
a broad cellular tropism. This broad cellular tropism is be-
cause widely spread receptors, such as integrins and the epider-
mal growth factor receptor, serve as entry receptors.14Y16 These are
also found on pancreatic A cells,17 making them putative targets
for CMV infection.
Studies addressing the cellular effects of CMV largely focus
on the infection of fully permissive ﬁbroblasts. In ﬁbroblasts,
the infection has a number of immunologic consequences, both
immunostimulatory to enhance viral replication and viral spread,
but also immunoevasive to prevent immune recognition and
elimination of the host cells. The immunostimulatory effects,
which are usually observed during the (immediate) early stages
of ﬁbroblast CMV infection, include the release of proin-
ﬂammatory cytokines and type 1 interferons18,19 and the up-
regulation of the T-cell stimulatory adhesion molecules ICAM-1
and LFA-3.20 The immunoevasive effects, which are usually
observed during the early to late stages of infection, include the
down-regulation of the cellular MHC I expression,21 as well as
the expression of virally encoded anti-inﬂammatory cytokines
and chemokine decoy receptors.12 Recently, we have demon-
strated that rat A cells show a marked increase in the cellular
immunogenicity after rat CMV infection, as demonstrated by
the increased expression of adhesion molecules ICAM-1 and
LFA-3, classic and nonclassic MHC I molecules, and Toll-like
receptor 2 (TLR-2).22 In the light of CMV-reinforced immune
responses, these results suggest that A-cell CMV infection and
subsequently increased immunologic recognizability may be a
mechanism of immune-mediated A-cell dysfunction in vivo.
As a model for HCMV-induced A-cell pathology, we in-
vestigated the susceptibility of human pancreatic A cells to
HCMV infection and the cellular immunologic consequences
of the infection in vitro. Subsequently, we determined the me-
chanism by which HCMV infection changes A-cell immunoge-
nicity. Finally, we evaluated whether HCMV-infected A cells are
able to activate peripheral blood mononuclear cells (PBMCs).
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MATERIALS AND METHODS
Study Design
The susceptibility of A cells to HCMV infection was de-
termined using human CM insulinoma cells (CM cells; n = 7)
and primary human A cells isolated from cadaveric pancreata
(n = 3). Although the insulin release of this CM line is not as
in native A cells,23,24 with respect to surface marker expression
the cell line demonstrates many similarities to native A cells.25
Further, the cell line has been proven to be predictive for im-
munologic consequences of viral infection in vitro26 and for the
susceptibility to autoimmune processes in type 1 diabetes.27 All
cell types were infected with the laboratory HCMV strain AD169
at a multiplicity of infection (MOI) of 0.01, 1, or 10 plaque-
forming units per cell (PFUs/cell). Infected permissive primary
human ﬁbroblasts served as controls (n = 6). The susceptibility
of A cells to HCMV infection was determined by assessing the
expression of viral UL111 and US28 transcripts and immediate
early-1 (IE1) and pp65 proteins. Viral protein expression was
analyzed at 24 to 96 hours after infection, whereas the expression
of UL111 and US28 was determined at 72 hours after infection.
To study the immunogenicity of the cells after infection, we
infected CM cells with AD169 at an MOI of 0.01, 1, or 10 PFUs/
cell (n = 7). This study was performed on CM cells because the
amount of cells required for these studies could not be obtained
from cadaveric pancreata. In accordance with our study in rat A
cells,22 we quantiﬁed the expression of the major histocompat-
ibility complexes HLA-A/B/C, the adhesion molecules ICAM-1
and LFA-3, and the TLR-2 in response to AD169 infection. These
molecules were quantiﬁed in response to AD169 infection at 24
to 96 hours after infection. Furthermore, the release of proin-
ﬂammatory and viral infectionYassociated IL-1A, IL-6, IL-8,
IL-15, interferon->, and Monocyte Chemotactic Protein-1 by CM
cells was quantiﬁed in response to AD169 infection. Because the
virus-induced effects were most prominent at 72 hours after
infection, the release of cytokines to infection at an MOI of 1 and
10 PFUs/cell was determined at this time point.
To study the mechanism of AD169-induced changes in
cellular immunogenicity and cytokine release, several experi-
ments were performed using virus particles which were UV-
inactivated before infection (n = 5). The UV inactivation of virus
particles completely abolishes viral replication. This allows us to
discriminate between cellular effects induced by viral replication
or protein expression and effects induced by viral binding and
cellular entry only.
Because the laboratory HCMV strain AD169 is adapted to
replication in ﬁbroblasts,28,29 it may be argued that infection using
this HCMV strain in A cells is not fully representative for clinical
HCMV infection. Therefore, key ﬁndings were repeated using the
clinical HCMV isolate Merlin at an MOI of 0.01 PFU/cell or 1
PFU/cell (n = 5). Low propagation rates of this HCMV strain
limited us to infections at an MOI of 0.01 and 1 PFU/cell in most
experiments.
Finally, the immune stimulatory capacity of AD169-
infected, Merlin-infected, noninfected CM cells, and CM cells
inoculated with UV-inactivated virus particles was analyzed
in a 3H-thymidine PBMC proliferation assay (n = 5 PBMC
donors). For this, CM cells were infected with infectious or
UV-inactivated AD169 virus particles at an MOI of 0.01 or 1
PFU/cell or with infectious or UV-inactivated Merlin at an
MOI of 0.01 PFU/cell for 72 hours.
Cell Lines, Primary Human A Cells, and PBMCs
Human islets were isolated from cadaveric pancreata in the
Leiden University Medical Center, as previously described.30
The Leiden University Medical Center has permission from the
Dutch government to act as an organ bank for human islets. The
organs, for which consent for research was obtained, were al-
located by the Eurotransplant Foundation (Leiden, The Nether-
lands). Use of anonymous donor material was acted on in
accordance with the Code of Proper Secondary Use of Human
Tissue in The Netherlands as formulated by the Dutch Federation
of Medical Scientiﬁc Societies. In The Netherlands and some
other countries in the Eurotransplant zone, permission for organ
donation is obtained after checking a national database of peo-
ple who have consented to organ donation during life and/or
interviews by the organ procurement team with relatives after
the diagnosis of brain death. Consent for research is obtained
verbally from relatives by the organ procurement team and put
in writing on organ donor reports. All donor organs are coded
(anonymized) when they arrive at the human islet isolation unit
at the Leiden University Medical Center. Primary human A cells
were isolated from dispersed islets, based on cellular ﬂavin ad-
enine dinucleotide ﬂuorescence.31
Peripheral blood mononuclear cells were isolated from the
blood of 5 healthy volunteers using a Lymphoprep density gra-
dient according to standard protocols (1.078 g/mL; Axis-Shield,
Oslo, Norway).
CM cells25 and primary human A cells were cultured in
RPMI (Gibco, Breda, The Netherlands) containing 60 Kg/mL
gentamicin and 10% heat-inactivated fetal calf serum (FCS).
Human fetal lung ﬁbroblasts were prepared from fetal lungs
in 1992. The necessary material was obtained from the women’s
clinic after approval of the Groningen University Medical Eth-
ical Committee and oral informed consent of both parents. Hu-
man fetal lung ﬁbroblasts (FLF92)32 were cultured in Dulbecco
modiﬁed Eagle medium (Gibco) containing 60 Kg/mL genta-
micin and 10% FCS. Cell lines (CM and FLF92) were always
used between passage numbers 5 and 20.
Human Cytomegalovirus Infection
Three days before infection, primary A cells, CM cells (both
300,000 cells per well), and FLF92 (250,000 cells per well) were
seeded in 6-well plates. One day before infection, cells were
serum-starved in culture medium containing 3% FCS (infection
medium). Thereafter, cells were infected with infectious HCMV
particles (the laboratory strain AD169 or the clinical strain
Merlin [kindly provided by Prof Puchhammer-Sto¨ckl, Medical
University of Vienna, Vienna, Austria]) at MOIs ranging from
0.01 to 10 PFUs/cell. Noninfected cell cultures in infection
medium served as controls. AD169 or Merlin infection was per-
formed for 1 hour in 1 mL of infection medium, after which
2 mL of infection medium was added. Infected and nonin-
fected cells were harvested using 0.05% Trypsin 0.5 mM EDTA.
Virus particles were UV-irradiated for 10 minutes at room
temperature. UV-inactivated virus particles were used imme-
diately. Complete inactivation of the particles was conﬁrmed
by the absence of viral protein expression after infection of
FLF92.
Immunocytochemistry
Cells (50,000) were spotted on glass slides, air-dried, ﬁxed,
and permeabilized using a CMV Brite Turbo Kit (IQ products,
The Netherlands). Subsequently, cells were stained for the cel-
lular expression of IE1 (clone E13; AbD Serotec, Du¨sseldorf,
Germany) and pp65 (clone C10YC11; Hybridoma derived) ac-
cording to standard protocols, using a horseradish peroxidaseY
conjugated secondary antibody and 3,3¶-diaminobenzidine tetra
HCl for staining.
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Viral Genes
Total RNA was extracted using TRIzol reagent (Gibco).
After DNAse treatment (DNAse-free; Ambion, Nieuwerkerk a/d
Ijssel, The Netherlands) complementary DNA was synthesized
(SuperScript III and OligodT primers; Invitrogen, Breda, The
Netherlands). Cellular viral transcripts UL111 and US28 were
detected on a ABI7900 TaqMan (Applied Biosystems, Carlsbad,
Calif ) using gene-speciﬁc primers (Table 1). Relative gene ex-
pression was normalized for the cellular expression of GAPDH
and depicted as the $Ct value.
Flow Cytometry
Cells were counted and ﬁxed in ice-cold phosphate-buffered
saline (PBS) containing 0.5% paraformaldehyde. Before staining,
the cells were washed and incubated with 10% rabbit serum for
30minutes. Cells were rinsed in PBS containing 1% bovine serum
albumin (BSA) and incubated with the primary antibody for
60 minutes. Primary antibodies used were antihuman ICAM-1
(Hu5/3-2.1; kindly provided by Dr M.A. Gimbrone, Harvard
Medical School, Boston, Mass), antiYLFA-3 (TS2/9.1.4.3; ATCC,
Manassas, Va), and antiYMHC I (W6/32; ATCC), all undiluted,
and biotin-conjugated antiYTLR-2 (1:50; BioLegend, Uithoorn,
The Netherlands). Secondary antibodies used were ﬂuorescein
isothiocyanateYconjugated rabbit antimouse (1:50; Dako,
Glostrup, Denmark) and ﬂuorescein isothiocyanateYconjugated
streptavidin (1:100; Dako). Cells were incubated with the sec-
ondary antibody for 30 minutes, and all incubations were carried
out on ice and in the dark. Phosphate-buffered saline/BSA was
used instead of the primary antibody as a negative control.
At least 10,000 cells were analyzed by ﬂow cytometry. The
percentage of positive cells was determined based on the sample
stained with PBS/BSA instead of the primary antibody. Data were
analyzed using Winlist 5.0 software (Verity Software House,
Topsham, Me). Protein expression levels of HCMV-infected cells
were compared with those of noninfected cells, and relative ex-
pression levels were calculated. Because 100% of the cells were
positive for MHC class I, ICAM-1, and LFA-3,26 the mean
ﬂuorescence intensity (MFI) levels were used to calculate the
relative expression levels. The cells demonstrated very low levels
of TLR-2, therefore the percentage of positive cells was used to
calculate these relative expression levels. Relative expression
levels are indicated as follows: expression level of the HCMV-
infected cells (MFI or %) / expression level of the noninfected
cells (MFI or %).
Cytokine Production
Culture supernatants were harvested, and cellular debris was
removed by centrifugation. The culture supernatants were stored
at j20-C until further use. A Biorad 6-plex luminex kit was
used to detect the presence of IL-1A, IL-6, IL-8, IL-15, IFN->,
and MCP-1 (Biorad, Veenendaal, The Netherlands). The assay
was performed according to the kit protocol.
3H-Thymidine Incorporation Assay
Human cytomegalovirusYinfected and noninfected cells
were used as stimulator cells. After 72 hours of infection, the
cells were harvested, washed, and ﬁxed in PBS containing 0,5%
paraformaldehyde for 5 minutes on ice. Fixed cells were stored
in liquid nitrogen until further use.
Peripheral blood mononuclear cells, at a concentration of
2  105, were coincubated with 2  104 stimulator cells (ratio,
10:1) for 72 hours in 96-well round-bottom plates at 37-C and
5% CO2 according to standard protocols.33 Peripheral blood
mononuclear cells incubated in RPMI 10% FCS (medium)
served as negative controls, whereas PBMCs incubated in me-
dium containing 5 KL/mL concanavalin A (ConA) served as
positive controls. Peripheral bloodmononuclear cells were labeled
with 1 KCi 3H-thymidine 16 hours before analysis. 3H-Thymidine
incorporation was measured using liquid scintillation.
Statistics
Results are expressed as the mean T SEM. Normality of the
data sets was determined using the Kolmogorov-Smirnov test. If
the data sets were not normally distributed, they were log-
transformed and reanalyzed using the Kolmogorov-Smirnov test.
Normally distributed data sets were analyzed using the (paired)
2-tailed Student t test or the 2-tailed 1-sample t test. When data
sets were not normally distributed, differences were calculated
using the Mann-Whitney U test or the Wilcoxon signed-rank
test. P values less than 0.05 were considered to be statistically
signiﬁcant.
RESULTS
Human A Cells and CM Cells Are Susceptible
to HCMV Infection
The susceptibility of human A cells to HCMV infection was
investigated in an in vitro infection assay. To this end, CM cells
were infected with the HCMV strain AD169 at an MOI of 0.01,
1, and 10 PFUs/cell. The cells were harvested 24 to 96 hours
after infection and stained for the IE1 protein and the early-late
pp65 protein. Noninfected CM cells and AD169-infected fully
permissive ﬁbroblasts served as controls.
At 72 hours after infection, viral proteinYexpressing CM
cells were observed in a dose-dependent manner, that is, MOI
0.01 PFU/cell, no IE1- or pp65-expressing cells detected (not
shown); MOI 1 PFU/cell, less than 1% IE1- and pp65-expressing
cells detected (Fig. 1A); and MOI 10 PFUs/cell, 4% IE1-
expressing CM cells and less than 1% pp65-expressing CM cells
detected (Fig. 1A). Compared with AD169-infected ﬁbroblasts,
the number of AD169-infected CM cells was profoundly lower
than the number of infected ﬁbroblasts, which demonstrated
50% to 80% IE1-expressing cells (MOI 1 and 10 PFUs/cell), and
10% to 40% pp65-expressing cells (Fig. 1A). This difference
between the 2 cell types is further substantiated by the obser-
vation that the number of IE1- and pp65-expressing CM cells
remained constant over time (up to 96 hours after infection),
whereas the number of AD169-infected ﬁbroblasts increased
over time, reaching an infection grade of almost 100% in 96 hours
after infection (data not shown). The susceptibility of human CM
cells to HCMV infection was conﬁrmed on mRNA level. Viral
immediate-early UL111 and early US28 transcripts were detected
in the cell cultures infected with AD169 for 72 hours but not in
the noninfected cultures (Fig. 1B).
To demonstrate the relevance of these ﬁndings for native
pancreatic A cells, the infectability of primary human A cells,
isolated from cadaveric pancreata, was studied. The cells were
infected with AD169 at an MOI of 1 PFU/cell for 72 hours and
analyzed for HCMV infection on an mRNA level. Human cy-
tomegalovirus infection of primary human A cells was demon-
strated by the presence of viral UL111 and US28 transcripts in
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the cells infected with AD169 but not in the noninfected cells
(Fig. 1C).
CMV Infection Increases the Cellular
Immunogenicity
Next, we investigated the immunologic consequence of the
A-cell HCMV infection by measuring the cellular expression of
MHC I, ICAM-1, LFA-3, and TLR-2. Because this study re-
quired large amounts of cells, we used CM cells rather than
primary human A cells. CM cells were AD169-infected at an
MOI of 0.01, 1, and 10 PFUs/cell and analyzed at 24 to 96 hours
after infection. Noninfected CM cells and infected ﬁbroblasts
served as controls.
AD169 infection of CM cells using an MOI of 0.01 PFU/
cell did not result in alterations in MHC I, ICAM-1, LFA-3, or
TLR-2 expression (data not shown). AD169 infection at an MOI
of 1 or 10 PFUs/cell induced a signiﬁcant increase in MHC class
I expression compared with noninfected CM cells (Fig. 2A, only
MOI 1 is presented). This increase was signiﬁcant at 72 hours
after infection. Further, the infection induced an increase in the
expression of ICAM-1 at 24 hours after infection (Fig. 2B),
whereas the cellular LFA-3 expression remained unaffected on
AD169 infection (Fig. 2C). The expression of TLR-2 was low on
CM cells and was not affected by the AD169 infection (data not
shown). The expression of MHC I and adhesion molecules in
AD169-infected CM cells was differently regulated compared
with AD169-infected ﬁbroblasts. Fibroblasts infected with AD169
at an MOI of 0.01 PFU/cell did not demonstrate any alterations
in the MHC I, ICAM-1, LFA-3, or TLR-2 expression (data not
shown). Fibroblasts infected at an MOI of 1 or 10 PFUs/cell
demonstrated decreasedMHC I expression and increased ICAM-1
and LFA-3 expression (Supplemental Figure 1, Supplemental
Digital Content 1, http://links.lww.com/MPA/A75, only MOI 1 is
presented). Fibroblast infection at an MOI of 10 PFUs/cell further
decreased the cellular MHC I expression but did not further in-
crease the cellular ICAM-1 expression (data not shown).
CMV Infection Induces the Release of
Proinﬂammatory Cytokines
We also studied the release of proinﬂammatory cytokines
from AD169-infected CM cells. Because AD169 infection at an
MOI of 0.01 PFU/cell did not result in viral protein expression
or alterations in CM cell immunogenicity, we only analyzed CM
cells that were infected with AD169 at an MOI 1 and 10 PFUs/
FIGURE 1. Human A cells and CM cells are susceptible to HCMV infection. A, Immunohistochemical staining of CM cells and fibroblasts.
Cells were AD169-infected at an MOI of 1 and 10 PFUs/cell. At 72 hours after infection, the cells were harvested. Subsequently,
the expression of viral IE1 and pp65 protein was determined by immunohistochemistry. A-Cells expressing IE1 or pp65 are depicted
by the arrows. B and C, Viral gene expression was analyzed by quantitative polymerase chain reaction. Human CM cells (B) and
primary human A cells (C) were AD169-infected. Gene expression of viral UL111 and US28 was detected 72 hours after infection.
Noninfected cells served as controls. Viral transcripts were not detected in noninfected controls and therefore not depicted
($Ct value 9 40). Transcriptional levels were corrected for the transcription of GAPDH ($Ct value).
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cell. At 24 to 96 hours after infection, the presence of IL-1A,
IL-6, IL-8, IL-15, IFN->, and MCP-1 was determined in the
culture supernatant of infected and noninfected CM cells.
Infected ﬁbroblasts served as controls.
After AD169 infection, the CM cells released IL-6, IL-8,
some IL-15, and MCP-1 in the culture supernatant, in a dose-
dependent manner (Figs. 3BYE). These cytokines were detected
in a similar pattern at all time points analyzed. Therefore, we only
show cytokine release at 72 hours after infection. The release of
IL-1A (Fig. 3A) and IFN-> (Fig. 3E) was not affected by the
AD169 infection. The release of cytokines from infected CM
cells was different compared with infected ﬁbroblasts, which re-
leased IL-1A, IL-6, IL-8, IL-15, and some IFN-> after AD169
infection (Supplemental Figure 2, Supplemental Digital Content
2, http://links.lww.com/MPA/A76). AD169 infection signiﬁcantly
decreased the ﬁbroblast MCP-1 release (Supplemental Figure 2,
Supplemental Digital Content 2, http://links.lww.com/MPA/A76).
Viral Binding Versus Viral Replication
Although only a few CM cells demonstrated viral gene
expression, the increase in immunogenicity was observed in a
large proportion of the CM cells. This suggests that binding of
the virus particles to the cells, or viral entry alone, is enough to
increase the cellular immunogenicity. To test this hypothesis,
CM cells and ﬁbroblasts were incubated with UV-inactivated
virus particles at an MOI of 1 and 10 PFUs/cell. Because our
previous results showed that virus-induced effects were most
prominent at 72 hours after infection, the cells were harvested
and analyzed at this time point.
The effect of AD169 infection on CM-cell MHC I up-
regulation was abrogated when the virus particles were UV-
inactivated (Fig. 4A). In contrast to the MHC I expression,
UV-inactivated virus particles increased the CM cell ICAM-1
expression in a similar manner compared with infectious virus
particles (Fig. 4B). In ﬁbroblasts, infection with UV-inactivated
virus completely abrogated the infection-induced down-regulation
of MHC I and even increased the expression of MHC I in a dose-
dependent manner (Supplemental Figure 3, Supplemental Digital
Content 3, http://links.lww.com/MPA/A77). Similar to infected
CM cells, the infection-induced up-regulation of ICAM-1was still
observed despite UV inactivation (Supplemental Figure 3, Sup-
plemental Digital Content 3, http://links.lww.com/MPA/A77).
FIGURE 2. HCMV infection increases the cellular immunogenicity. Human CM cells (n = 7) were AD169-infected at an MOI of
1 PFU/cell. Subsequently, the cellular expression of MHC class I (A), ICAM-1 (B), and LFA-3 (C) was determined by flow cytometry
from 24 to 96 hours after infection. All graphs show the mean T SEM of relative expression levels of AD169-infected cells compared
with uninfected control cells. All panels show representative flow cytometry graphs. The graphs show cells stained with the secondary
antibody only (filled gray), uninfected cells stained with both primary and secondary antibodies (thin black line), and HCMV-infected
cells stained with both primary and secondary antibodies (bold black line). *P G 0.05. **P G 0.01.
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After incubating CM cells with UV-inactivated virus par-
ticles, CM cells released similar quantities of IL-6, IL-8, IL-15,
and MCP-1 compared with infectious virus particles (Figs. 4CYH
compared with Fig. 3). Also in ﬁbroblasts, the release of cy-
tokines in response to UV-inactivated virus was similar to the re-
lease proﬁle observed after inoculating with infectious virus
particles (Supplemental Figure 3, Supplemental Digital Content
3, http://links.lww.com/MPA/A77). However, UV inactivation
of AD169 abrogated the ﬁbroblast MCP-1 down-regulation
(Supplemental Figure 3, Supplemental Digital Content 3,
http://links.lww.com/MPA/A77).
Clinical Isolates Versus Laboratory Strains of CMV
Key ﬁndings of CM cell infection with AD169 were re-
peated using the clinical HCMV isolateMerlin. Low propagation
rates of this virus strain limited us to infections at anMOI of 0.01
PFU/cell in most of the experiments. Again, noninfected CM
cells and Merlin-infected ﬁbroblasts served as controls.
Merlin infection of CM cells resulted in similar ﬁndings
compared with AD169; at 72 hours after infection, less than 1%
of IE1- and pp65-expressing CM cells were found using an MOI
of 1 PFU/cell, whereas infection at an MOI of 0.01 PFU/cell did
not demonstrate any IE1- or pp65-positive cells (Fig. 5A). Similar
to AD169-infected ﬁbroblasts, Merlin infection of ﬁbroblasts
resulted in large numbers of IE1- (10% and 80%) and pp65-
expressing cells (5% and 30%) (Fig. 5A).
Comparable to AD169-infected CM cells, Merlin infection
increased the cellular expression of MHC I at 48 to 72 hours after
infection (Fig. 5B). The ICAM-1 expression was increased at 24
to 48 hours after infection (Fig. 5C). CM cell LFA-3 expression
was not affected by Merlin infection (not shown). In contrast to
AD169-infected ﬁbroblasts, Merlin infection increased the cel-
lular expression of MHC I, as well as the ICAM-1 and LFA-3
expression (Supplemental Figure 4, Supplemental Digital Con-
tent 4, http://links.lww.com/MPA/A78).
CMV-Infected A Cells Potently Activate
Human PBMCs
The previously mentioned results indicate that A cells may
not only be infected by HCMV, but they may also activate the
immune system because of their increased immunogenicity. To
test this hypothesis, we determined the immunostimulatory ca-
pacity of HCMV-infected A cells. For this, we quantiﬁed the
3H-thymidine incorporation in PBMCs on exposure to nonin-
fected CM cells, 72-hour (UV-inactivated) AD169-infected CM
cells (MOI 0.01 and 1 PFU/cell), (UV-inactivated) Merlin-
infected CM cells (MOI 0.01 PFU/cell), medium alone, or
FIGURE 3. HCMV infection induces the release of proinflammatory cytokines. Human CM cells (AYF) were AD169-infected
at a concentration of 1 or 10 PFUs/cell (CMV 1 or 10, respectively). At 72 hours after infection, the culture medium was harvested,
and the concentration of IL-1A (A), IL-6 (B), IL-8 (C), IL-15 (D), IFN-> (E), and MCP-1 (F) was quantified by Luminex. All graphs show
the mean T SEM. *P G 0.05. **P G 0.01.
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ConA. Peripheral blood mononuclear cell proliferation to
AD169- and Merlin-infected ﬁbroblasts served as a control. The
PBMC proliferation rates to infected and noninfected cells were
calculated as a percentage of the PBMC proliferation observed
after ConA stimulation (10,026 T 1865 disintegrations per sec-
ond, which was set to 100% for each individual experiment).
CM cells infected with AD169 at an MOI of 1 PFU/cell
induced 7.7% of the maximal proliferation, which was signiﬁ-
cantly higher than PBMC proliferation to noninfected CM cells
(3.4% of maximal proliferation; Fig. 6). CM cells infected with
Merlin at an MOI of 0.01 PFU/cell induced 7.5% of the maximal
proliferation, which was signiﬁcantly higher than the PBMC
proliferation to noninfected CM cells (3.4% of maximal prolif-
eration; Fig. 6). Peripheral blood mononuclear cell prolifera-
tion to Merlin-infected CM cells was signiﬁcantly higher than
PBMC proliferation to CM cells infected with AD169 at a
similar MOI of 0.01 PFU/cell (3.6% of maximal proliferation;
Fig. 6). Peripheral blood mononuclear cell proliferation to
Merlin-infected CM cells decreased when the virus particles
were UV-inactivated before infection (5.1% of maximal prolif-
eration). However, CM cells inoculated with UV-inactivated
Merlin still increased PBMC proliferation above the level ob-
served after stimulating with noninfected CM cells (Fig. 6). CM
cells inoculated with UV-inactivated AD169 at anMOI of 1 PFU/
cell induced similar PBMC proliferation rates as CM cells in-
oculated with infectious AD169 particles (Fig. 6).
Only ﬁbroblasts infected with AD169 at an MOI of 1 PFU/
cell were able to increase PBMC proliferation (10.1% of maxi-
mal proliferation), whereas Merlin-infected ﬁbroblasts failed
to increase the PBMC proliferation above the level of PBMC
proliferation to noninfected ﬁbroblasts (6.4% of maximal pro-
liferation; Supplemental Figure 5, Supplemental Digital Content
5, http://links.lww.com/MPA/A79).
DISCUSSION
In the present study, we investigated the susceptibility of
human pancreatic A cells to HCMV infection together with the
associated immunologic consequences of the infection. We show
that human pancreatic A cells, as demonstrated by both primary
A cells as well as CM insulinoma cells, are susceptible to HCMV
infection, replication, and viral protein expression. The infection
had large immunologic consequences, which were demonstrated
by an infection-induced increase in the cellular immunogenicity
and the release of proinﬂammatory cytokines. Although virus-
speciﬁc responses are observed, a similar increase in A-cell MHC
FIGURE 4. Viral binding versus viral replication. Human CM cells were AD169-infected with UV-inactivated nonreplicating virus
at a concentration of 1 or 10 PFUs/cell (CMV 1 or 10, respectively). At 72 hours after infection, the cellular expression of MHC I (A)
and ICAM-1 (B) was determined by flow cytometry. In addition, culture medium was harvested for quantification of IL-1A (C), IL-6 (D),
IL-8 (E), IL-15 (F), IFN-> (G), and MCP-1 (H) by Luminex. All graphs show the mean T SEM. *P G 0.05. **P G 0.01.
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I expression and proinﬂammatory cytokine and chemokine re-
lease was observed after infection with other diabetes-associated
viruses, such as measles, mumps, rubella,26 or coxsackie virus.34
Our results are in line with the fact that HCMV-infected A cells
increased their capacity to activate immune cells. Our results
furthermore demonstrated that parts of the A-cell response to
HCMVare due to binding of the virus or cellular entry only, that
is, ICAM-1 up-regulation and cytokine release, whereas for some
molecules, such as MHC I, regulation is dependent on viral rep-
lication. Next to the laboratory HCMV strain AD169, we also
tested the infectability, effects on immunogenicity, and activa-
tion of immune cells after infection of A cells with the clinical
HCMV strain Merlin. We found results similar to the effects of
AD169. That the immunologic consequences of cellular HCMV
infection are highly cell typeYspeciﬁc was shown by ﬁbroblasts,
which demonstrated a rather different regulation of immune cell
activating ligands and cytokines compared with HCMV-infected
A cells.
Although the presence of IE1- and pp65-expressing A cells
clearly demonstrated that pancreatic A cells are directly sus-
ceptible to HCMV infection, the replication process proceeds
much slower in A cells than in ﬁbroblasts. That this mode of
HCMV replication is cell typeYspeciﬁc, rather than dependent
on adaptations of the laboratory strain AD169, was demonstrated
by a similar infection grade using the clinical HCMV strain
Merlin. This strengthens the hypothesis that pancreatic A cells
do support HCMV infection and replication, similar to several
other CMV-supporting cell types in humans35Y44 and A cells
in rats.22 This is further substantiated by two other ﬁndings. First,
the presence of active viral replication in A cells was demon-
strated by the regulation of MHC I in the presence of infectious
virus particles but not when the viral replication was abolished
by UV inactivation. Second, we observed a marked activation
of immune cells in response to HCMV-infected CM cells. Be-
cause PBMC activation and proliferation are restricted to the
presentation of viral antigens on MHC I, these results suggests
that, although viral protein expression in infected A cells may
be hard to detect using conventional laboratory techniques, the
cells do allow viral replication and protein expression, which in
turn can be detected by the immune system. This observation
is of clinical importance because persistent low-grade infection
of native pancreatic A cells may explain the absence of overt
A-cell CMV infection in vivo, despite clear cut effects of the
CMV infection on A-cell function and survival.1,45
We demonstrate not only that human pancreatic A cells are
susceptible to HCMV infection but also that the virus induced
the release of proinﬂammatory cytokines and increased the
cellular immunogenicity. This increased cellular immunogenic-
ity may enhance the intrinsic capacity of pancreatic A cells to
activate T cells, making HCMV-infected A cells even more prone
to (auto- and/or allo-) immune-mediated destruction. If the pro-
duction of proinﬂammatory cytokines is also observed in vivo,
FIGURE 5. Human CM cells are susceptible to Merlin infection. Human CM cells were Merlin-infected at a concentration of 1 or
0.01 PFU/cell. At 72 hours after infection the cellular expression of IE1 and pp65 (A) was determined as a measure for Merlin infection.
In addition, the expression of MHC I (B) and ICAM-1 (C) was determined in A cells infected with 0.01 PFU/cell Merlin. All graphs
show the mean T SEM. *P G 0.05. **P G 0.01.
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a CMV-induced local proinﬂammatory cytokine environment
in the native pancreas, or in islet grafts, may further contribute
to T-cell activation and proliferation.46 In fact, proinﬂamma-
tory cytokine release in vivo has been demonstrated to directly
compromise A-cell function and viability34 and to recruit and
activate autospeciﬁc or allospeciﬁc immune cells.47Y51 In addi-
tion, inhibition of islet cytokine release has been associated with
decreased insulitis52 and improved islet graft function.53,54 Fur-
thermore, the association between up-regulation of ICAM-1 and
MHC-I and the destruction of islet cells have been demonstrated
in several studies. For example, administration of blocking anti-
bodies directed against ICAM-1 signiﬁcantly improved islet
allograft survival.55 Also, it has been demonstrated that in-
creased A-cell antigen presentation by MHC I is associated with
autoimmune destruction of native A cells.56,57 Together, this
suggests that an increased cellular immunogenicity, combined
with an enhanced immune cellYactivating capacity of the in-
fected A cells, may have direct deleterious consequences in vivo.
The clinical relevance of our study is further substantiated
by the ﬁndings using the clinical HCMV isolate Merlin. Infec-
tion of CM cells with this clinical HCMV strain enhanced the
cellular immunogenicity and induced immune cell activation
compared with noninfected and AD169-infected cells. The time
frame in which the immunologic changes occurred was similar
to that of the laboratory strain AD169. However, the clinical
isolate induced approximately 2.5 times more MHC I and
ICAM-1 expression than the laboratory strain. This is remark-
able because the clinical isolate was used in a 100-fold lower
concentration than the laboratory AD169 strain. This not only
suggests that genetic differences between the clinical and labo-
ratory strain58 are responsible for differentially affecting A-cell
immunogenicity but also strongly underlines the deleterious
potential of clinical HCMV infection for pancreatic A-cell sur-
vival in vivo.
Most immunologic effects in A cells, for example, proin-
ﬂammatory cytokine release and ICAM-1 up-regulation, are also
observed after UV inactivation of the virus. This suggests that
sensing of the virus via viral binding or viral entry is an im-
portant mechanism in HCMV-enhanced A cells immunogenicity.
It is therefore tempting to speculate that similar to ﬁbroblasts,
these effects may be mediated through interactions between the
virus and pattern recognition receptors on the cellular surface.19
Alternatively, the A-cell response may also be mediated through
intracellular sensing of unmethylated CpG regions in the viral
DNA or sensing of viral RNA.59Y61 The interactions between
HCMVand pattern recognition receptors are well described and
are thought to be necessary for nuclear factor JB activation and
subsequent expression of the viral immediate early genes.62,63
Another consequence of this nuclear factor JB activation is the
expression and release of proinﬂammatory factors, such as IL-6
and IL-8,19,62 and the up-regulation of ICAM-1.64 This mecha-
nism of action may also hold true for HCMV-infected A cells
as well.
A marked difference between HCMV-infected ﬁbroblasts
and A cells was the regulation of MHC I. On infection, ﬁbroblasts
demonstrated down-regulation ofMHC I, whereas infected A cells
demonstrated a marked up-regulation of MHC I. The regulation
of MHC I after HCMV infection has been demonstrated before
to be highly cell typeYspeciﬁc42,65Y69 and may be explained
by cell-speciﬁc differences in the course of the infection and thus
the expression of viral proteins. In ﬁbroblasts, the down-regulation
of MHC I is dependent on the cellular expression of viral
immediate-early protein US3 and early-late proteins US2, US6,
US10, and US11 and serves to prevent immune recognition of
FIGURE 6. HCMV-infected A cells potently activate human PBMCs. Human cytomegalovirusYinfected or noninfected A cells (CM
insulinoma cells) were coincubated with PBMCs from healthy donors for 72 hours. CM cells were inoculated with either infectious
(black bars) or UV-inactivated nonreplicating (dashed bars) virus of the AD169 strain (MOI 0.01 PFU/cell and MOI 1 PFU/cell)
or the Merlin strain (MOI 0.01 PFU/cell) for 72 hours. Peripheral blood mononuclear cells incubated with medium alone were
included as negative controls, whereas PBMCs incubated with ConA served as positive controls. Peripheral blood mononuclear cell
proliferation was determined by measuring 3H-thymidine incorporation. Peripheral blood mononuclear cell proliferation was
determined as the percentage of the total proliferative capacity of the cells as observed after ConA stimulation (100%). All graphs
show the mean T SEM. H,a,#P G 0.05. HH,##P G 0.01. HHHP G 0.001. HStatistical significance compared with proliferation to noninfected
cells. aStatistical significance between different viral strains. #Statistical significance between infectious and UV-inactivated virus.
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infected cells.21 In case of low-grade HCMV infection in A cells,
the absence of US3, US2, US6, US10, and/or US11 protein ex-
pression may therefore prevent MHC I down-regulation. The ob-
served up-regulation of MHC I in infected A cells may be the
result of immediate-early viral gene expression because UV in-
activation abolished the increase in the cellular MHC I expres-
sion and demonstrated the dependence on (parts) of the viral
replicative cycle.
In addition to immunogenicity studies on HCMV-infected
A cells, we also demonstrated that HCMV infection of the A cells
increases the cellular capacity to activate T cells. The HCMV-
induced increased expression of MHC I and adhesion molecules
may further add to antigen presentation and T-cell costimulation.
By using UV-inactivated virus, we demonstrate the importance
of this increased cellular immunogenicity. Because viral repli-
cation and protein expression is abolished after UV inactivation,
only low amounts of viral proteins can be presented on MHC I
(only proteins from viruses that entered the cell). Although ac-
tivation of PMBCs is signiﬁcantly decreased after stimulation
with A cells coincubated with UV-inactivated virus particles
compared with A cells coincubated with infectious virus parti-
cles, the PBMC proliferation was still signiﬁcantly increased
compared with noninfected A cells. Thus, although UV inacti-
vation strongly decreased the level of viral antigen presented
on MHC I, the HCMV-induced increased immunogenicity may
still provide enough costimulation to induce a potent immune
activation.
In conclusion, we demonstrate that, using primary A cells
and the CM insulinoma model, human A cells are directly sus-
ceptible to low-grade HCMV infection, as demonstrated by in-
fection with the laboratory strain AD169 and the clinical isolate
Merlin. Moreover, we demonstrate that HCMV sensing together
with low-grade replication and viral gene expression has large
immunologic consequences. Both viral infection and increased
immunogenicity may lead to potent stimulation of immune cells.
We propose a model in which in vivo low-grade viral infection of
the native or transplanted A cells, combined with an enhanced
cellular immunogenicity and a local proinﬂammatory cytokine
environment provokes a strong and destructive immune response
against the insulin producing A cells. This might be a mechanism
responsible for HCMV-induced A-cell dysfunction in new-onset
type 1 diabetes mellitus,1Y5 the development of posttransplanta-
tion diabetes mellitus,6Y8 and islet allograft failure.9Y11
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